Andrew. M. Scharenberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew. M. Scharenberg has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Jaya Sahni
Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA
9 shared publicationsDavid J. Rawlings
Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA
7 shared publicationsJordan Jarjour
Bluebird Bio, Seattle, WA 98102, USA
7 shared publicationsBarry L. Stoddard
Department of Immunology, 2Medical Scientist Training Program, University of Washington, Seattle, WA, 98195, 3Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, WA, 98101, 4Pregenen Inc., Seattle, WA, 98103, 5Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, 6Department of Biochemistry and 7Department of Biostatistics, University of Washington, Seattle, WA, 98195, USA
5 shared publications- David J. Rawlings
Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA
5 shared publications Guillermo S. Romano Ibarra
Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA
5 shared publications
Latest Publications
- Open Access
- 28 September 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 45 (3) , e11
Characterization of homing endonuclease binding and cleavage specificities using yeast surface display SELEX (YSD-SELEX)
LAGLIDADG homing endonucleases (LHEs) are a class of rare-cleaving nucleases that possess several unique attributes for genome engineering applications. An important approach for advancing LHE technology is the generation of a library of design ‘starting points’ through the discovery and characterization of natural LHEs with diverse specificities. However, while identification of natural LHE proteins by sequence homology from genomic and metagenomic sequence databases is straightforward, prediction of corresponding target sequences from genomic data remains challenging. Here, we describe a general approach that we developed to circumvent this issue that combines two technologies: yeast surface display (YSD) of LHEs and systematic evolution of ligands via exponential enrichment (SELEX). Using LHEs expressed on the surface of yeast, we show that SELEX can yield binding specificity motifs and identify cleavable LHE targets using a combination of bioinformatics and biochemical cleavage assays. This approach, which we term YSD-SELEX, represents a simple and rapid first principles approach to determining the binding and cleavage specificity of novel LHEs that should also be generally applicable to any type of yeast surface expressible DNA-binding protein. In this marriage, SELEX adds DNA specificity determination to the YSD platform, and YSD brings diagnostics and inexpensive, facile protein-matrix generation to SELEX.
- 28 September 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 45 (3) , e11
Open AccessCharacterization of homing endonuclease binding and cleavage specificities using yeast surface display SELEX (YSD-SELEX)
LAGLIDADG homing endonucleases (LHEs) are a class of rare-cleaving nucleases that possess several unique attributes for genome engineering applications. An important approach for advancing LHE technology is the generation of a library of design ‘starting points’ through the discovery and characterization of natural LHEs with diverse specificities. However, while identification of natural LHE proteins by sequence homology from genomic and metagenomic sequence databases is straightforward, prediction of corresponding target sequences from genomic data remains challenging. Here, we describe a general approach that we developed to circumvent this issue that combines two technologies: yeast surface display (YSD) of LHEs and systematic evolution of ligands via exponential enrichment (SELEX). Using LHEs expressed on the surface of yeast, we show that SELEX can yield binding specificity motifs and identify cleavable LHE targets using a combination of bioinformatics and biochemical cleavage assays. This approach, which we term YSD-SELEX, represents a simple and rapid first principles approach to determining the binding and cleavage specificity of novel LHEs that should also be generally applicable to any type of yeast surface expressible DNA-binding protein. In this marriage, SELEX adds DNA specificity determination to the YSD platform, and YSD brings diagnostics and inexpensive, facile protein-matrix generation to SELEX.
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S301
761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T Cells
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S301
Open Access761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T Cells
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S18
40. Nuclease-Targeted Gene-Editing of FOXP3 in Primary T Cells Creates a Stable and Functional T reg Phenotype
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S18
Open Access40. Nuclease-Targeted Gene-Editing of FOXP3 in Primary T Cells Creates a Stable and Functional T reg Phenotype
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S158
398. Site-Specific Introduction of Chimeric Antigen Receptors to Primary Human T Cells
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S158
Open Access398. Site-Specific Introduction of Chimeric Antigen Receptors to Primary Human T Cells
- 30 September 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (307) , 307ra156
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Therapeutic coding sequences can be targeted to the CCR5 locus of primary human T cells with high efficiency by using megaTAL nuclease and an AAV donor template.
- 30 September 2015
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (307) , 307ra156
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Therapeutic coding sequences can be targeted to the CCR5 locus of primary human T cells with high efficiency by using megaTAL nuclease and an AAV donor template.
- Open Access
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S273
685. Efficient Targeted Gene Modification in Primary Human Hematopoietic Cells Using Co-Delivery of Nuclease mRNA and AAV Donors
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S273
Open Access685. Efficient Targeted Gene Modification in Primary Human Hematopoietic Cells Using Co-Delivery of Nuclease mRNA and AAV Donors
- Open Access
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S226
567. Enhanced Efficiency of CRISPR-Mediated Gene Knock-Out in Primary Human T-Cells
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S226
Open Access567. Enhanced Efficiency of CRISPR-Mediated Gene Knock-Out in Primary Human T-Cells
- Open Access
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S174-S175
441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine Model of In Vivo Foamy Virus Gene Therapy for Severe Combined Immunodeficiency
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S174-S175
Open Access441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine Model of In Vivo Foamy Virus Gene Therapy for Severe Combined Immunodeficiency
- Open Access
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S113-S114
284. High-Efficiency Targeted Introduction of an Anti-CD19 CAR Into the CCR5 Locus in Primary Human T Cells
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S113-S114
Open Access284. High-Efficiency Targeted Introduction of an Anti-CD19 CAR Into the CCR5 Locus in Primary Human T Cells
- 3 November 2014
- Published by Springer Nature
- Vol. 1239, 171-196
Assembly and Characterization of megaTALs for Hyperspecific Genome Engineering Applications
Rare-cleaving nucleases have emerged as valuable tools for creating targeted genomic modification for both therapeutic and research applications. MegaTALs are novel monomeric nucleases composed of a site-specific meganuclease cleavage head with additional affinity and specificity provided by a TAL effector DNA binding domain. This fusion product facilitates the transformation of meganucleases into hyperspecific and highly active genome engineering tools that are amenable to multiplexing and compatible with multiple cellular delivery methods. In this chapter, we describe the process of assembling a megaTAL from a meganuclease, as well as a method for characterization of nuclease cleavage activity in vivo using a fluorescence reporter assay.
- 3 November 2014
- Published by Springer Nature
- Vol. 1239, 171-196
Assembly and Characterization of megaTALs for Hyperspecific Genome Engineering Applications
Rare-cleaving nucleases have emerged as valuable tools for creating targeted genomic modification for both therapeutic and research applications. MegaTALs are novel monomeric nucleases composed of a site-specific meganuclease cleavage head with additional affinity and specificity provided by a TAL effector DNA binding domain. This fusion product facilitates the transformation of meganucleases into hyperspecific and highly active genome engineering tools that are amenable to multiplexing and compatible with multiple cellular delivery methods. In this chapter, we describe the process of assembling a megaTAL from a meganuclease, as well as a method for characterization of nuclease cleavage activity in vivo using a fluorescence reporter assay.